Nutriband CEO Gareth Sheridan joins Steve Darling from Proactive to share how its latest AVERSA fentanyl abuse deterrent product is looking to make an impact by reducing the opioid epidemic. Sheridan says that the past year has shown major growth for Nutriband as it pursues FDA approval for AVERSA, along with making new partnerships and acquisitions.
Nutriband Shares How its AVERSA Patch is Taking On the Opioid Epidemic
